Philogen S.p.A. (BIT:PHIL)
Italy · Delayed Price · Currency is EUR 24.25
+1.10 (4.75%)
Jul 27, 2026, 5:35 PM CET
Philogen Revenue
In the year 2025, Philogen had annual revenue of 320.12M EUR with 312.25% growth. Philogen had revenue of 311.40M in the half year ending December 31, 2025, with 11,886.18% growth.
Revenue
320.12M
Revenue Growth
+312.25%
P/S Ratio
3.06
Revenue / Employee
1.49M
Employees
214
Market Cap
976.82M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 320.12M | 242.47M | 312.25% |
| Dec 31, 2024 | 77.65M | 52.53M | 209.12% |
| Dec 31, 2023 | 25.12M | -2.17M | -7.96% |
| Dec 31, 2022 | 27.30M | 22.33M | 449.86% |
| Dec 31, 2021 | 4.96M | -1.38M | -21.77% |
| Dec 31, 2020 | 6.35M | -10.17M | -61.58% |
| Dec 31, 2019 | 16.52M | 767.00K | 4.87% |
| Dec 31, 2018 | 15.75M | 1.63M | 11.55% |
| Dec 31, 2017 | 14.12M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 2.65B |
| Amplifon | 2.39B |
| DiaSorin | 1.17B |
| Safilo Group | 983.38M |
| EL.En. | 595.51M |
| GPI S.p.A. | 546.18M |
| Garofalo Health Care | 489.26M |
| Svas Biosana | 141.56M |
Philogen News
- 2 months ago - Philogen Earnings release: Q1 2026 - Filings
- 4 months ago - Philogen Earnings Call Transcript: H2 2025 - Transcripts
- 4 months ago - Philogen Annual report: H2 2025 - Filings
- 4 months ago - Philogen Earnings release: H2 2025 - Filings
- 9 months ago - Philogen Earnings release: Q3 2025 - Filings
- 10 months ago - Philogen Earnings Call Transcript: H1 2025 - Transcripts
- 10 months ago - Philogen Quarterly report: H1 2025 - Filings
- 10 months ago - Philogen Earnings release: H1 2025 - Filings